A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma

BACKGROUND: Concurrent chemotherapy and radiation is the standard treatment for unresectable stage III Lung adenocarcinoma. However, no optimal concurrent chemotherapeutic regimen has been described. This study aimed to assess concurrent pemetrexed, nedaplatin and thoracic intensity-modulated radiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yiyu, Gu, Weiguang, Deng, Jin, Yang, Hua, Yang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054621/
https://www.ncbi.nlm.nih.gov/pubmed/27717315
http://dx.doi.org/10.1186/s12885-016-2800-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054621/
https://www.ncbi.nlm.nih.gov/pubmed/27717315
http://dx.doi.org/10.1186/s12885-016-2800-5

Ejemplares similares